Business Standard

Zydus Lifesciences Share Price

Know More
BSENSE

976.95 7.95 (0.82%)

04:01 PM, 18-Dec-2024

979.55 9.65 (0.99%)

03:49 PM, 18-Dec-2024

BSE : 532321

NSE : ZYDUSLIFE

Sector : Health care

ISIN Code : INE010B01027

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 18-Dec-2024 | 04:01 PM IST

Market Cap (₹ Cr)

98,301

Traded Value (₹ Cr)

1.14

Volume (Shares)

11,664

Face Value (₹)

1

52-Week High (₹)

1,323.90

52-Week High Date

09-Aug-2024

52-Week Low (₹)

648.05

52-Week Low Date

21-Dec-2023

All Time High (₹)

1,323.90

All Time High Date

09-Aug-2024

All Time Low (₹)

5.53

All Time Low Date

25-Jul-2001

Zydus Lifesciences Ltd

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development) manufacturing marketing and selling of finished dosage human formulations (generics branded generics and specialty formulations including biosimilars and vaccines) Active Pharmaceutical Ingredients (APIs) animal healthcare products and consumer wellness products. The Company operate manufacturing facilities at Ahmedabad Ankleshwar and Vadodara in Gujarat Ponda in Goa Raigad in Maharashtra and Solan in Himachal Pradesh.Founded by the Late Promoter Mr. ...
Read More

Zydus Lifesci. News

Zydus Lifesciences Q2 result: Net profit rises 13.8% to Rs 911.2 crore

2 min read

WHO approves Zydus Lifesciences' typhoid vaccine for UN procurement

2 min read

This pharma stock has zoomed 57% thus far in 2024; Citi sees more upside

3 min read

Zydus Lifesciences gets USFDA nod for generic schizophrenia treatment drug

1 min read

Zydus Lifesciences receives USFDA approval to produce prostrate cancer drug

1 min read

Zydus gets USFDA approval to produce its generic prostate cancer drug

2 min read
More

Zydus Lifesciences Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

98,562

EPS - TTM (₹) [C]

42.51

P/E Ratio (X) [C]

23.04

Face Value (₹) 1
Latest Dividend (%)300.00
Latest Dividend Date 26-Jul-2024
Dividend Yield (%) 0.31
Book Value Share (₹) [C]216.89
P/B Ratio (₹) [C]4.52

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Kotak Flexi Cap Fund (G) 1014.25 1,05,00,000 1.98
Kotak Flexi Cap Fund (IDCW) 1014.25 1,05,00,000 1.98
Kotak Flexi Cap Fund - Direct (G) 1014.25 1,05,00,000 1.98
Kotak Flexi Cap Fund - Direct (IDCW) 1014.25 1,05,00,000 1.98
Parag Parikh Flexi Cap Fund (G) 855.75 88,59,127 1.01
Parag Parikh Flexi Cap Fund - Direct (G) 855.75 88,59,127 1.01
ICICI Pru Bluechip Fund (G) 346.07 35,82,740 0.54
ICICI Pru Bluechip Fund (IDCW) 346.07 35,82,740 0.54
ICICI Pru Bluechip Fund - Direct (G) 346.07 35,82,740 0.54
ICICI Pru Bluechip Fund - Direct (IDCW) 346.07 35,82,740 0.54

Load more

Research Reports

DateBrokerActionPrices(₹) Report
02-Sep-2024Elara Capital Buy 1,497
26-Aug-2024Motilal Oswal Neutral 1,210
12-Aug-2024ICICI Securities Reduce 1,120
29-May-2024Geojit Financial Services Accumulate 1,196
19-May-2023Prabhudas Lilladher Accumulate 520

Stock Strength

Today's Low/High (₹)

968.30

984.00

Week Low/High (₹)

955.05

994.00

Month Low/High (₹)

933.60

1,000.00

Year Low/High (₹)

648.15

1,324.00

All time Low/High (₹)

5.53

1,324.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-0.68%-0.70%-1.65-1.80%
1 Month3.66%3.69%3.683.18%
3 Month-9.25%-9.30%-3.33-4.64%
6 Month-9.20%-9.21%3.732.72%
1 Year43.90%43.92%12.4312.98%
3 Year113.08%113.18%40.6442.47%

Company Info

Company Information

Chairman (Non-Executive) : Pankaj R Patel

Managing Director : Sharvil P Patel

Non Executive Director : Mukesh M Patel

Independent Director : Apurva S Diwanji

Whole-time Director : Ganesh N Nayak

Independent Director : Bhadresh K Shah

Company Sec. & Compli. Officer : Dhaval N Soni

Independent Director : Akhil A. Monappa

Independent Director : Upasana Konidela.

Independent Director : Shelina P. Parikh

Registered Office: Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W,Ahmedabad,Gujarat-382481 Ph: 91-079-26868100

Email:dhavalsoni@zyduscadila.com; upen.shah@zyduscadila.

URL:http://www.zyduscadila.com

FAQs about Zydus Lifesciences Ltd

1. What's the Zydus Lifesciences Ltd share price today?
Zydus Lifesciences Ltd share price was Rs 976.95 at 04:01 PM IST on 18th Dec 2024. Zydus Lifesciences Ltd share price was up by 0.82% over the previous closing price of Rs 969.00. Zydus Lifesciences Ltd share price trend:

  • Last 1 Month: Zydus Lifesciences Ltd share price moved up by 3.66% on BSE
  • Last 3 Months: Zydus Lifesciences Ltd share price moved down by 9.25% on BSE
  • Last 12 Months: Zydus Lifesciences Ltd share price moved up by 43.90% on BSE
  • Last 3 Years: Zydus Lifesciences Ltd price moved up by 113.08% on BSE


2. How can I quickly analyse the performance of the Zydus Lifesciences Ltd stock?
The performance of the Zydus Lifesciences Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 23.04
  • Price to book value ratio is 4.52
  • Dividend yield of 0.31
  • The EPS (trailing 12 months) of the Zydus Lifesciences Ltd stock is Rs 42.51


3. What is the market cap of Zydus Lifesciences Ltd?
Zydus Lifesciences Ltd has a market capitalisation of Rs 98,301 crore.


4. What is Zydus Lifesciences Ltd's 52-week high/low share price?
The Zydus Lifesciences Ltd’s 52-week high share price is Rs 1,323.90 and 52-week low share price is Rs 648.05.


5. Is the Zydus Lifesciences Ltd profitable?
On a consolidated basis, Zydus Lifesciences Ltd reported a profit of Rs 789.80 crore on a total income of Rs 2,947.30 crore for the quarter ended 2024. For the year ended Sep 2024, Zydus Lifesciences Ltd had posted a profit of Rs 898.10 crore on a total income of Rs 5,305.50 crore.


6. Which are Zydus Lifesciences Ltd’s peers in the Health care sector?
Zydus Lifesciences Ltd’s top 5 peers in the Health care sector are Torrent Pharma., Mankind Pharma, Dr Reddy's Labs, Zydus Lifesci., Lupin, Aurobindo Pharma, Alkem Lab.


7. Who owns how much in Zydus Lifesciences Ltd?
Key changes to the Zydus Lifesciences Ltd shareholding are as follows:

  • Promoter holding in Zydus Lifesciences Ltd has gone up to 74.98 per cent as of Sep 2024 from 74.98 per cent as of Dec 2023.